Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

7,313 total articles

Boyd Gaming Chairman Executes $8.45 Million in Stock Sales

Boyd Gaming Chairman Executes $8.45 Million in Stock Sales

Marianne Boyd Johnson, the Chairman of Boyd Gaming Corp (NASDAQ: BYD), has completed a series of stock transactions totaling approximately $8.45 million. The sales involved the disposal of 100,000 shares of the company's common stock through the Marianne Boyd Johnson Gaming Properties Trust, an entity for which Ms. Johnson serves as trustee. These …

Acadian Asset Management Executive Executes $6.7 Million Stock Sale

Acadian Asset Management Executive Executes $6.7 Million Stock Sale

Richard Jonathan Hart, who serves as the Chief Legal Officer and Chief Administrative Officer at Acadian Asset Management Inc. (NASDAQ: AAMI), has completed a significant sale of company common stock. On May 4, 2026, Mr. Hart disposed of shares totaling $6,697,021. This transaction occurred while the company's stock was trading near its 52-week hig…

United Airlines Executive Disposes of $631,330 in Common Stock

United Airlines Executive Disposes of $631,330 in Common Stock

Andrew P. Nocella, serving as the Executive Vice President and Chief Commercial Officer for United Airlines Holdings, Inc. (NASDAQ: UAL), has completed a sale of company shares. The transaction, which occurred on May 1, 2026, involved the disposal of 7,000 shares of common stock at a price point of $90.19 per share. This specific trade resulted in …

Acadia Pharmaceuticals Executive Executes Mandatory Stock Sale Amid Regulatory and Valuation Shifts

Acadia Pharmaceuticals Executive Executes Mandatory Stock Sale Amid Regulatory and Valuation Shifts

James Kihara, the Principal Accounting Officer at Acadia Pharmaceuticals Inc (NASDAQ: ACAD), has completed a sale of common stock totaling $29,024. The transaction occurred on May 4, 2026, involving the disposal of 1,332 shares. This move follows a recent acquisition of shares through the vesting of restricted stock units (RSUs). As the company pre…

JPMorgan Chief Risk Officer Executes $1.26 Million Stock Sale

JPMorgan Chief Risk Officer Executes $1.26 Million Stock Sale

Ashley Bacon, the Chief Risk Officer for JPMorgan Chase & Co. (NYSE: JPM), has completed a sale of company common stock totaling approximately $1.26 million. The transaction occurred on May 5, 2026, marking a notable movement in executive equity holdings. This insider activity takes place against a backdrop of various institutional developments wit…